S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Pfizer and Protalix BioTherapeutics Announce FDA Approval of Pediatric Indication for ELELYSO™ (taliglucerase alfa) for Injection, for Intravenous Use for the Treatment of Type 1 Gaucher Disease|
|INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of PLX Technology, Inc. of Class Action Against Its Board of Directors in Connection With the Sale of the Company to Avago Technologies Limited -- PLXT|
|PLX Technology, Inc. Reports Second Quarter 2014 Financial Results|
|LAWSUIT ALERT: The Law Firm of Andrews & Springer LLC Announces That A Class Action Lawsuit Has Been Filed Against PLX Technology, Inc. -- PLXT|
|Shareholder Alert: Brower Piven Announces Class Action Lawsuit in Connection With the Sale of PLX Technology, INC. -- PLXT|
|Avago Technologies Limited Successfully Completes Tender Offer for Shares of PLX Technology, Inc. -- Acquisition to Close Today|
|UPDATE: Cash-rich spending spree is sign of a growing tech bubble (2014/8/7)|
|United Therapeutics Advances to Second Cohort in Phase I Trial of Pluristem's PLX-PAD Cells for Treatment of Pulmonary Arterial Hypertension|
|Avago Technologies Limited Announces Third Quarter Fiscal Year 2014 Financial Results|
|Pluristem Initiates South Korean Arm of Multinational Phase II Intermittent Claudication Trial|
Click above to view more mutual fund data and stats for plx - Protalix BioTherapeutics Inc.